Centenial Surgical Suture Ltd vs Molbio Diagnostics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Centenial Surgical Suture Ltd is ₹ 71.25 as of 26 Oct 15:30 . The P/E Ratio of Centenial Surgical Suture Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Centenial Surgical Suture Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The Revenue of Centenial Surgical Suture Ltd is ₹ 0 crore as of Jun '25 .The Revenue of Molbio Diagnostics Ltd is ₹ 100.47 crore as of Jun '25 . The EBITDA of Centenial Surgical Suture Ltd is ₹ 0 crore as of Jun '25 .The EBITDA of Molbio Diagnostics Ltd is ₹ -15.35 crore as of Jun '25 . The Net Profit of Centenial Surgical Suture Ltd is ₹ 0 crore as of Jun '25 .The Net Profit of Molbio Diagnostics Ltd is ₹ -23.94 crore as of Jun '25 . The Dividend Payout of Centenial Surgical Suture Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Centenial Surgical Suture Ltd

Incorporated in 1995, Centenial Surgical Suture Limited is engaged in the manufacture and sale of surgical sutures in India.
The company offers absorbable sutures that include natural and synthetic sutures and non absorbable sutures comprising needles for cardiovascular surgery, monofilament polyamide atraumatic needle suture combinations, monofilament stainless steel, and temporary pacemaker electrodes.
It also provides female urinary incontinency sets, titanium haemostatic clips for cardiovascular surgery, non absorbable. Company leverages the expertise and application knowledge of the global suture requirements for cardiovascular sutures in particular, to bring advanced atraumatic needle product development to the Indian Surgeons.
Continuous innovation in the areas of design, research and development of atraumatic needle, simulation and validation, testing and services, are the key value creation driver for the Company.

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

FAQs for the comparison of Centenial Surgical Suture Ltd and null

Which company has a larger market capitalization, Centenial Surgical Suture Ltd or Molbio Diagnostics Ltd?

Market cap of Centenial Surgical Suture Ltd is 25 Cr while Market cap of Molbio Diagnostics Ltd is 14,689 Cr

What are the key factors driving the stock performance of Centenial Surgical Suture Ltd and Molbio Diagnostics Ltd?

The stock performance of Centenial Surgical Suture Ltd and Molbio Diagnostics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Centenial Surgical Suture Ltd and Molbio Diagnostics Ltd?

As of October 31, 2026, the Centenial Surgical Suture Ltd stock price is INR ₹71.25. On the other hand, Molbio Diagnostics Ltd stock price is INR ₹1274.65.

How do dividend payouts of Centenial Surgical Suture Ltd and Molbio Diagnostics Ltd compare?

To compare the dividend payouts of Centenial Surgical Suture Ltd and Molbio Diagnostics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.